Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9603 posts found.

Latest news from Datamonitor

October 24, 2007 Research and Development

Abraxis gets FDA approval for chemotherapy drugAbraxis Pharmaceutical Products, the hospital-based business of Abraxis BioScience, has received FDA approval to …
News

Latest news from Datamonitor

October 18, 2007 Research and Development

Advaxis cancer vaccine shows encouraging resultsBiotechnology company Advaxis has announced positive results from a Phase I/II first-in-man trial of a …
News

Pfizer to set up separate biotech arm

October 11, 2007 Research and Development

Pfizer has unveiled its new strategy in research and development, including senior appointments and the setting up of an independent …
News

Gates Foundation invests $100m in unorthodox research

October 10, 2007 Research and Development

Scientists with novel ideas for research into some of the world's biggest diseases are to be offered a new source …
News

Latest news from Datamonitor

October 9, 2007 Research and Development

Critical Therapeutics starts Phase I trial of zileutonCritical Therapeutics has initiated a phase I clinical trial to assess the safety …
News

Wyeth buys Scottish biotech firm

October 8, 2007 Research and Development

Wyeth is to acquire Haptogen, a biotech research company based in Aberdeen which has a unique approach to targeting the …
News

Latest news from Datamonitor

October 1, 2007 Research and Development

Cubicin approved for marketing in CanadaCubist Pharmaceuticals has said that Health Canada has approved Cubicin for marketing in Canada, where …
News

Leukaemia drug enters phase III studies in MS

September 28, 2007 Research and Development

Patients with multiple sclerosis could benefit from a drug currently used to treat leukaemia, with late-stage trials now commencing.Discovered by …
News

BMS makes $430m biotech acquisition

September 27, 2007 Research and Development

Bristol-Myers Squibb has significantly advanced its strategy to move into biologics with the acquisition of US biotech Adnexus.The $430 million …
News

UK clinical trials: on the mend?

September 26, 2007 Research and Development UK, clinical trials, global, research

How clinical research is organised in the UK is essential to the success of Britain's pharma industry, and to the …
Feature

Pfizer’s Celsentri approved in Europe

September 25, 2007 Research and Development, Sales and Marketing HIV

Pfizer's Celsentri has been approved in Europe, making it the first in a new, oral class of HIV drugs in …
News

Latest news from Datamonitor

September 17, 2007 Research and Development, Sales and Marketing

Cell Therapeutics launches Phase III study for pixantroneCell Therapeutics has launched its phase III clinical trial, known as PIX303, of …
News

UK stem-cell research to benefit from hybrid embryos decision

September 10, 2007 Research and Development stem cell

A new ruling on the use of hybrid human-animal embryos could help UK researchers extend their lead over European rivals.The …
News

Latest news from Datamonitor

September 10, 2007 Research and Development, Sales and Marketing

Akela reports positive results for Fentanyl Taifun trialAkela Pharma has reported promising results from a phase IIb trial for its …
News

AZ opens clinical pharmacology unit in China

September 6, 2007 Research and Development China, em

AstraZeneca has opened its first ever clinical pharmacology unit in China, providing support for more trials to be carried out …
News
The Gateway to Local Adoption Series

Latest content

Thermo Fisher opens new distribution centre in Ireland

March 12, 2026

Altimetrik appoints Dhirendra Nath as Chief Human Resources Officer

March 12, 2026

Kindeva appoints Mike Cowhig as Chief Legal Officer

March 11, 2026

DiaMedica gets regulatory clearance from Health Canada for phase 2 preeclampsia study

March 11, 2026

Abselion establishes a US subsidiary in Massachusetts 

March 10, 2026